Document 2L9o5QeddDe24YkQ4pvdkzxN

To: From: Cc: Bcc: Received Date: Subject: Clegg, Patsy M SCC-DCS/22 <patsy.clegg@shell.com> michael. g. bi rd @exxonmobil.com <michael. g. bi rd @exxonmobil.com> 2007-03-15 13:50: 50 GMT Re:SHS Patsy, I'm sorry to have missed your call. I do confirm that Mark Fitzsimmons & I were able to speak with Richard to acknowledge his response and that his points had been forwarded to Jerry Rice; he was quite positive and would take these up with the QA/QC team which he would be convene in the next few days. I gave feedback to the Tech Committee and would be pleased to do so during the Oversight call. Best regards, Michael Michael G. Bird, PhD., DABT Toxicology & Environmental Sciences Division, ExxonMobil Biomedical Sciences, Inc. 1545 Route 22 East P.O. Box 971 Annandale, New Jersey 08801-0971 tel: 9087301060 fax: 908 730 1199 Email: michael.g.bird@exxonmmobil.com This document and all information contained within this electronic message may be privileged, confidential and exempt from disclosure under applicable law. It is intended only for the use of the individual(s) and/or entity(ies) named above. If you are not the intended recipient, you are on notice that any unauthorized disclosure, copying, distribution, or taking of any action in reliance on the contents of the electronically transmitted materials is prohibited. SH ELL-MCCLU RG-062027